tiprankstipranks
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
RESEARCH TOOLSreports

Jasper Therapeutics (JSPR) Financial Statements

1,056 Followers

Jasper Therapeutics Financial Overview

Jasper Therapeutics's market cap is currently $22.46M. The company's EPS TTM is $-0.32; its P/E ratio is -0.96; Jasper Therapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.06M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -80.52M$ -76.24M$ -68.86M$ -51.20M$ -36.83M
EBITDA$ -82.83M$ -74.87M$ -67.75M$ -50.22M$ -36.46M
Net Income$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Balance Sheet
Cash & Short-Term Investments$ 28.69M$ 71.64M$ 86.89M$ 38.25M$ 84.70M
Total Assets$ 35.78M$ 79.90M$ 94.89M$ 48.36M$ 93.65M
Total Debt$ 1.24M$ 1.81M$ 2.79M$ 3.65M$ 2.88M
Net Debt$ -27.46M$ -69.82M$ -84.10M$ -34.60M$ -81.82M
Total Liabilities$ 31.63M$ 18.23M$ 16.45M$ 12.37M$ 24.14M
Stockholders' Equity$ 4.15M$ 61.67M$ 78.44M$ 35.99M$ 69.52M
Cash Flow
Free Cash Flow$ -77.17M$ -63.15M$ -52.33M$ -46.43M$ -36.11M
Operating Cash Flow$ -77.16M$ -62.60M$ -52.07M$ -45.86M$ -33.68M
Investing Cash Flow$ 5.00K$ -532.00K$ -267.00K$ -576.00K$ -2.43M
Financing Cash Flow$ 34.21M$ 47.88M$ 100.97M$ 55.00K$ 100.97M
Currency in USD

Jasper Therapeutics Earnings and Revenue History

Income Statement >

Jasper Therapeutics Debt to Assets

Balance Sheet >

Jasper Therapeutics Cash Flow

Cash Flow >

Jasper Therapeutics Forecast EPS vs Actual EPS

Earnings >